As of 2026-09-19, the Relative Valuation of Inozyme Pharma Inc (INZY) is (34.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.00 USD, the upside of Inozyme Pharma Inc based on Relative Valuation is -951.3%.
The range of the Relative Valuation is (31.41) - (39.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 23.8x | 21.4x |
| Forward P/E multiples | 15.7x - 23.9x | 19.8x |
| Fair Price | (31.41) - (39.34) | (34.05) |
| Upside | -885.2% - -1083.5% | -951.3% |
| Date | P/E |